Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells-Reference-Cited by-同舟云学术

Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells

Published:2011-11-30 Issue:11 Volume:2 Page:874-885
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Dufies Maeva¹²³,Jacquel Arnaud¹²³,Belhacene Nathalie¹²³,Robert Guillaume¹²³,Cluzeau Thomas¹²³⁴,Luciano Fréderic¹²³,Cassuto Jill Patrice²⁴,Raynaud Sophie²⁵,Auberger Patrick¹²³⁴

Affiliation:

1. INSERM U895, Centre Méditerranéen de Médecine Moléculaire, Team «Cell Death, Differentiation, Inflammation and Cancer», Nice, France

2. Université de Nice Sophia Antipolis, Faculté de Médecine, Nice, France

3. Equipe labellisée par la Ligue Nationale Contre le Cancer 2011-2013, Paris, France

4. Service d'Hématologie Clinique et de Transplantation, Nice, France

5. Service d'Oncohématologie, Nice France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AXL inhibition prevents RPA2/CHK1-mediated homologous recombination to increase PARP inhibitor sensitivity in hepatocellular carcinoma;Heliyon;2024-09

2. AXL – a new player in resistance to HER2 blockade;Cancer Treatment Reviews;2023-12

3. Inhibition of a new AXL isoform, AXL3, induces apoptosis of mantle cell lymphoma cells;Blood;2023-10-26

4. TAM family kinases as therapeutic targets at the interface of cancer and immunity;Nature Reviews Clinical Oncology;2023-09-04

5. AXL/Gas6 signaling mechanisms in the hypothalamic-pituitary-gonadal axis;Frontiers in Endocrinology;2023-06-15